P

Inventor

MCHARDY STANTON F

US13 patents
⚠️ This page may combine multiple inventors who share the name “MCHARDY STANTON F”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CURTANA PHARMACEUTICALS INC

4 patents
US12145913B2Nov 19, 2024

Inhibition of Olig2 activity

CURTANA PHARMACEUTICALS INC0 citations55
US11242323B2Feb 8, 2022

Inhibition of OLIG2 activity

CURTANA PHARMACEUTICALS INC0 citations55
US11685722B2Jun 27, 2023

Inhibition of Olig2 activity

CURTANA PHARMACEUTICALS INC0 citations45
US11691951B2Jul 4, 2023

Inhibition of Olig2 activity

CURTANA PHARMACEUTICALS INC0 citations42

PFIZER

3 patents
US7049335B2May 23, 2006

3-azabicyclo[3.1.0]hexane derivatives

PFIZER40 citations89
US6444679B1Sep 3, 2002

4-phenyl-4-heteroarylpiperidine derivatives

PFIZER8 citations72
USRE40838EJul 7, 2009

2-azabicyclo[3.3.1]nonane derivatives

PFIZER2 citations61

MCHARDY STANTON F

3 patents
US8124639B2Feb 28, 2012

Bicyclic [3.1.0] heteroaryl amides as type 1 glycine transport inhibitors

MCHARDY STANTON F13 citations82
US8653108B1Feb 18, 2014

Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors

MCHARDY STANTON F5 citations66
US8772345B2Jul 8, 2014

Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors

MCHARDY STANTON F3 citations56

PFIZER PROD INC

1 patent
US6960609B2Nov 1, 2005

1-diphenylmethyl-pyrazole derivatives as opioid receptor ligands

PFIZER PROD INC4 citations56

UNIV TEXAS

1 patent
US11304916B2Apr 19, 2022

Methods and compositions for the treatment of Shiga Toxicosis

UNIV TEXAS0 citations50

SOUTHWEST RES INST

1 patent
US9169220B2Oct 27, 2015

Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors

SOUTHWEST RES INST0 citations46